This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (1)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

A. Robert Kagan, MD

JAMA. 1981;246(10):1124-1126.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

CANCER of the endolarynx is not common, but neither is it rare. Of the tobacco-induced malignant neoplasms, 12 pulmonary carcinomas to one cancer of the endolarynx are encountered. However, unlike cancer of the lung, laryngeal carcinoma is not only treatable but highly curable. The common sites of origin of carcinoma of the endolarynx include the supraglottic region (above the vocal cords), the glottic region (at the vocal cords), and the subglottic region (below the vocal cords).

The endolarynx is divided into the following anatomic sites: laryngeal surface of the epiglottis, laryngeal surface of the arytenoid region, false cord, ventricle, true cord, and subglottis.

Early lesions involve one or two sites and are designated T1 or T2, respectively. An example is a carcinoma confined to one vocal cord for Tl, or vocal cord carcinoma with either false cord or subglottic involvement for T2; T3 or T4 lesions are advanced tumors and . . . [Full Text PDF of this Article]

Author Affiliations
From the Department of Radiation Therapy, Southern California Permanente Medical Group, Los Angeles.

Footnotes
Reprint requests to Department of Radiation Therapy, Southern California Permanente Medical Group, Los Angeles, CA 90027 (Dr Kagan).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?